Back to Search
DAVID CLEMMONS, MD
MD
Internal Medicine Physician
NPI: 1649343401Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
Research & Publications (20)
Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer.
PMID 17906644·Nat Rev Drug Discov·2007
6-review
IGF-I assays: current assay methodologies and their limitations.
PMID 17429590·Pituitary·2007
6-review
Long-acting forms of growth hormone-releasing hormone and growth hormone: effects in normal volunteers and adults with growth hormone deficiency.
PMID 18174751·Horm Res·2007
6-review
Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
PMID 17426090·J Clin Endocrinol Metab·2007
2-rct
Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress.
PMID 17412627·Growth Horm IGF Res·2007
6-review
Value of insulin-like growth factor system markers in the assessment of growth hormone status.
PMID 17336738·Endocrinol Metab Clin North Am·2007
6-review
Involvement of insulin-like growth factor-I in the control of glucose homeostasis.
PMID 17030015·Curr Opin Pharmacol·2006
6-review
Clinical utility of measurements of insulin-like growth factor 1.
PMID 16932333·Nat Clin Pract Endocrinol Metab·2006
6-review
Quantitative measurement of IGF-I and its use in diagnosing and monitoring treatment of disorders of growth hormone secretion.
PMID 15879688·Endocr Dev·2005
6-review
Recombinant, nonglycosylated human insulin-like growth factor-binding protein-3 (IGFBP-3) is degraded preferentially after administration to type II diabetics, resulting in increased endogenous glycosylated IGFBP-3.
PMID 16189247·J Clin Endocrinol Metab·2005
8-other
Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
PMID 16005252·Growth Horm IGF Res·2005
8-other
Interaction between insulin-like growth factor-I receptor and alphaVbeta3 integrin linked signaling pathways: cellular responses to changes in multiple signaling inputs.
PMID 15528274·Mol Endocrinol·2005
6-review
The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity.
PMID 14702105·J Clin Invest·2004
7-preclinical
Role of insulin-like growth factor iin maintaining normal glucose homeostasis.
PMID 15761237·Horm Res·2004
7-preclinical
Minireview: Integral membrane proteins that function coordinately with the insulin-like growth factor I receptor to regulate intracellular signaling.
PMID 12697669·Endocrinology·2003
6-review
Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm.
PMID 14557452·J Clin Endocrinol Metab·2003
6-review
Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis.
PMID 11920405·Arthritis Rheum·2002
7-preclinical
Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly.
PMID 12812310·Pituitary·2002
6-review
Use of mutagenesis to probe IGF-binding protein structure/function relationships.
PMID 11739334·Endocr Rev·2001
6-review
Commercial assays available for insulin-like growth factor I and their use in diagnosing growth hormone deficiency.
PMID 11684882·Horm Res·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 MANNING DR
CHAPEL HILL, NC 27599 - Phone
- (919) 966-8596
Quick Facts
- NPI
- 1649343401
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile